A Review of Bleeding Risk with Impella-supported High-risk Percutaneous Coronary Intervention

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Devices

Background:

• High-risk percutaneous coronary intervention (HR-PCI) is frequently performed with mechanical circulatory support (MCS).
• Impella heart pumps are increasingly used for MCS in HR-PCI, offering greater hemodynamic support than traditional devices.
• Large-bore access required for Impella devices is linked to potential bleeding and vascular complications.

Purpose of the Study:

• To comprehensively review reported bleeding and vascular complications associated with Impella-supported HR-PCI.
• To consolidate variable published data on the risks of large-bore access for Impella devices.

Main Methods:

• Systematic review of published reports on bleeding and vascular complications in Impella-supported HR-PCI.
• Analysis of data concerning the incidence and nature of complications related to large-bore access.

Main Results:

• Data on bleeding and vascular complications associated with large-bore access for Impella devices are highly variable.
• Impella-related bleeding risk is a significant factor influencing clinical decisions for planned use in HR-PCI.

Conclusions:

• Further investigation is needed to better define the risk-benefit profile of Impella use in HR-PCI.
• Understanding complication rates is crucial for optimizing patient selection and procedural management during Impella-supported HR-PCI.